Cargando…

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

AIM: To assess the prevalence of a panel of serologic markers that reflect gut barrier dysfunction in a mixed cohort of pediatric and adult primary sclerosing cholangitis (PSC) patients. METHODS: Sera of 67 PSC patients [median age (range): 32 (5-79) years, concomitant IBD: 67% and cirrhosis: 20%] w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tornai, Tamas, Palyu, Eszter, Vitalis, Zsuzsanna, Tornai, Istvan, Tornai, David, Antal-Szalmas, Peter, Norman, Gary L, Shums, Zakera, Veres, Gabor, Dezsofi, Antal, Par, Gabriella, Par, Alajos, Orosz, Peter, Szalay, Ferenc, Lakatos, Peter Laszlo, Papp, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550791/ https://www.ncbi.nlm.nih.gov/pubmed/28839442 http://dx.doi.org/10.3748/wjg.v23.i29.5412

Ejemplares similares

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2018)

Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
por: Papp, Maria, et al.
Publicado: (2016)

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
por: Tornai, David, et al.
Publicado: (2021)

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?
por: Papp, Maria, et al.
Publicado: (2010)

Serological biomarkers for management of primary sclerosing cholangitis
por: Tornai, David, et al.
Publicado: (2022)

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients
por: Kovacs, Gyorgy, et al.
Publicado: (2018)

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation
por: Palyu, Eszter, et al.
Publicado: (2018)

The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis
por: Janka, Tamás, et al.
Publicado: (2023)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort
por: Pár, Alajos, et al.
Publicado: (2014)

Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies
por: Mátis, Dóra, et al.
Publicado: (2023)

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
por: Hunyady, Béla, et al.
Publicado: (2018)

Emerging medical therapies for severe alcoholic hepatitis
por: Tornai, David, et al.
Publicado: (2020)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
por: Meinel, Katharina, et al.
Publicado: (2022)

Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
por: Tornai, David, et al.
Publicado: (2018)

A Preliminary Quantitative Electron Microscopic Analysis Reveals Reduced Number of Mitochondria in the Infralimbic Cortex of Rats Exposed to Chronic Mild Stress
por: Csabai, Dávid, et al.
Publicado: (2022)

Serum Thymidine Kinase Activity: Analytical Performance, Age-Related Reference Ranges and Validation in Chronic Lymphocytic Leukemia
por: Szánthó, Eszter, et al.
Publicado: (2014)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Wastewater-based modeling, reconstruction, and prediction for COVID-19 outbreaks in Hungary caused by highly immune evasive variants
por: Polcz, Péter, et al.
Publicado: (2023)

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Investigation of the physical aspects of beta imaging probes using scintillating fibers and visible light photon counters
por: MacDonald, L R, et al.
Publicado: (1995)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?
por: Fickert, Peter, et al.
Publicado: (2007)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

Sclerosing Cholangitis in Behçet's Disease
por: Ben Slama Trabelsi, Aida, et al.
Publicado: (2013)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Randomized controlled trial protocol: balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease
por: Capato, Tamine Teixeira da Costa, et al.
Publicado: (2015)

An overview of recent treatment options for primary sclerosing cholangitis
por: Mousavere, Ioanna, et al.
Publicado: (2023)

The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia
por: Lopens, Steffi, et al.
Publicado: (2020)

Measurement of Soluble Biomarkers by Flow Cytometry
por: Antal-Szalmás, Péter, et al.
Publicado: (2013)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging
por: Möller, Kathleen, et al.
Publicado: (2022)

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients
por: Lakatos, Peter Laszlo, et al.
Publicado: (2007)

Secondary Sclerosing Cholangitis and Hodgkin’s Lymphoma
por: Abedi, Seyed Hassan, et al.
Publicado: (2015)

Secondary Sclerosing Cholangitis During Pregnancy
por: Abdulqader, Yasir, et al.
Publicado: (2016)

Treatment of primary sclerosing cholangitis in children
por: Laborda, Trevor J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jpq4burnikdm9lmd3gr96naks7